|
[1]KAMISAWA T,FUNATA N,HAYASHI Y,et al.A new clinicopathological entity of Ig G4-related autoimmune disease[J].J Gastroenterol,2003,38(10):982-984.
|
|
[2]BJRNSSON E,CHARI ST,SMYRK TC,et al.Immunoglobulin G4 associated cholangitis:description of an emerging clinicaentity based on review of the literanlre[J].Hepatology,2007,45(6):1547-1554.
|
|
[3]BEUERS U,BOBERG KM,CHAPMAN RW,et al.EASL clinical practice guidelines:management of cholestatic liver diseases[J].J Hepatol,2009,51(2):237-267.
|
|
[4]CHAPMAN R,FEVERY J,KALLOO A,et al.Diagnosis and management of primary sclerosing cholangitis[J].Hepatology,2010,51(2):660-678.
|
|
[5]ZEN Y,KAWAKAMI H,KIM JH.Ig G4-related sclerosing cholangitis:all we need to know[J].J Gastroenterol,2016,51(4):295-312.
|
|
[6]CHARI ST,SMYRK TC,LEVY MJ,et al.Diagnosis of autoimmune pancreatitis:the Mayo Clinic experience[J].Clin Gastroenterol Hepatol,2006,4(8):1010-1016.
|
|
[7]NAKAZAWA T,ANDO T,HAYASHI K,et al.Diagnostic procedures for Ig G4-related sclerosing cholangitis[J].J Hepatobiliary Pancreat Sci,2011,18(2):127-136.
|
|
[8]OHARA H,OKAZAKI K,TSUBOUCHI H,et al.Clinical diagnostic criteria of Ig G4-related sclerosing cholangitis 2012[J].J Hepatobiliary Pancret Sci,2012,19(5):536-542.
|
|
[9]LI P,LI YZ.Progress in diagnosis and treatment of Ig G4-related hepatobiliary diseases[J].J Clin Hepatol,2014,30(5):396-399.(in Chinese)李萍,李永哲.Ig G4相关肝胆疾病诊疗进展[J].临床肝胆病杂志,2014,30(5):396-399.
|
|
[10]ZHANG YA,SHEN XZ,ZHU JM,et al.Extensive metastatic cholangiocarcinoma associated with Ig G4-related sclerosing cholangitis misdiagnosed as isolated Ig G4-related sclerosing cholangitis:a case report and literature review[J].Medicine(Baltimore),2015,94(45):1-8.
|
|
[11]WANG NN,SUN MJ.Ig G4-related sclerosing cholangitis complicated by autoimmune pancreatitis:a clinical analysis of 8 cases[J].Shandong Med J,2015,55(8):43-45.(in Chinese)王宁宁,孙明军.Ig G4相关硬化性胆管炎并自身免疫性胰腺炎8例临床分析[J].山东医药,2015,55(8):43-45.
|
|
[12]NOVOTNY I,DT EP,TRMA J,et al.Immunoglobulin G4-related cholangitis:a variant of Ig G4-related systemic disease[J].Dig Dis,2012,30(2):216-219.
|
|
[13]NAITOH I,NAKAZAWA T,HAYASHI K,et al.Comparison of intraductal ultrasonography findings between primary sclerosing cholangitis and Ig G4-related sclerosing cholangitis[J].J Gastroenterol Hepatol,2015,30(6):1104-1109.
|
|
[14]ZEN Y,BRITTON D,MITRA V,et al.A global proteomic study identifies distinct pathological features of Ig G4-related and primary sclerosing cholangitis[J].Histopathology,2016,68(6):796-809.
|
|
[15]YIN DL,LIU LX,JIANG HC.Advances in diagnosis and treatment of Ig G4-related cholangitis[J].Chin J Pract Surg,2016,34(12):1194-1196.(in Chinese)尹大龙,刘连新,姜洪池.Ig G4相关胆管炎诊治进展[J].中国实用外科杂志,2016,34(12):1194-1196.
|
|
[16]XU BL,TU CT.A case report of Ig G4-related sclerosing cholangitis[J].J Clin Hepatol,2015,31(11):1910-1911.(in Chinese)徐蓓莉,涂传涛.Ig G4相关性硬化性胆管炎1例报告[J].临床肝胆病杂志,2015,31(11):1910-1911.
|
|
[17]NAVANEETHAN U,GUTIERREZ NG,JEGADEESAN R,et al.Ig G4 levels in bile for distinguishing Ig G4-associated cholangiopathy from other biliary disorders:a single blinded pilot study[J].Clin Endosc,2014,47(6):555-559.
|
|
[18]SAH RP,CHARI ST.Autoimmune pancreatitis:an update on classification,diagnosis,natural history and management[J].Curr Gastroenterol Rep,2012,14(2):95-105.
|
|
[19]HART PA,TOPAZIAN MD,WITZIG TE,et al.Treatment of relapsomg autoimmune pancreatitis with immunomodulators and rituximab:the Mayo Clinic experience[J].Gut,2013,62(1):1606-1615.
|
|
[20]KHOSROSHAHI A,STONE JH.Treatment approaches to Ig G4-related systemic disease[J].Curr Opin Rheumatol,2010,23(1):67-71.
|
|
[21]TOMIYAMA T,UCHIDA K,MASUSHITA M,et al.Comparison of steroid pulse therapy and conventional oral steroid therapy as initial threatment for autoimmune pancretitis[J].J Gastroenterol,2011,46(5):696-704.
|
|
[22]IWASAKI S,KAMISAWA T,KOIZUMI S,et al.Assessment in steroid trial for Ig G4-related sclerosing cholangitis[J].Adv Med Sci,2015,60(2):211-215.
|
|
[23]YOU MW,KIM JH,BYUN JH,et al.Relapse of Ig G4-related sclerosing cholangitis after steroid therapy:image findings and risk factors[J].Eur Radiol,2014,24(5):1039-1048.
|
|
[24]CLENDENON JN,ARANDA-MICHEL J,KRISHNA M,et al.Recurrent liver failure caused by Ig G4 associated cholangitis[J].Ann Hepatol,2011,10(4):562-564.
|
|
[25]KHOSROSHAHI A,CARRUTHERS MN,DESHPANDE V,et al.Rituximab for the treatment of Ig G4-related disease:lessons from10 consecutive patients[J].Medicine,2012,91(1):57-66.
|
|
[26]KHOSROSHAHI A,BLOCH DB,DESHPANDE V,et al.Rituximab theraphy leads to rapid decline of serum Ig G4 levels and prompt clinical improvenment in Ig G4-related systemic disease[J].Arthritis Rheum,2010,62(6):1755-1762.
|
|
[27]MA YM,SHANG LH,CHEN HG.Clinical effect of integrated traditional Chinese and Western medicine therapy in treatment of Ig G4-related cholangitis:an analysis of 36 cases[J].Jiangxi Chin Med,2015,46(396):42-44.(in Chinese)马悦茗,尚龙华,陈惠根.中西医结合治疗Ig G4相关性胆管炎36例[J].江西中医药,2015,46(396):42-44.
|
|
[28]ZHANG J,LI B,LI F,et al.Clinical effect of integrated traditional Chinese and Western medicine therapy in treatment of primary sclerosing cholangitis[J].Mod J Integr Tradit Chin West Med,2013,22(28):3132-3133.(in Chinese)张健,李冰,李梵,等.中西医结合治疗原发性硬化性胆管炎疗效观察[J].现代中西医结合杂志,2013,22(28):3132-3133.
|
|
[29]CHENG LP,FU J,GENG L,et al.Ig G4-related sclerosing cholangitis:a case report and literature review[J].J Hepatobiliary Surg,2015,23(2):117-120.(in Chinese)程利鹏,付军,耿利,等.Ig G4相关硬化性胆管炎一例并国内文献复习[J].肝胆外科杂志,2015,23(2):117-120.
|
|
[30]KHOSROSHAHI A,WALLACE ZS,CROWE JL,et al.International consensus guidance statement on the management and treatment of Ig G4-related disease[J].Arthritis Rheum,2015,67(7):1688-1699.
|
DownLoad: